Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01774487 · ClinicalTrials.gov registry record · Phase 2
Pentoxifylline Therapy in Biliary Atresia
A Phase 2 study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT01774487 is a Phase 2 study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 17 participants.
The verdict
NCT01774487, a Phase 2 study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pentoxifylline reduces liver damage in infants with biliary atresia.
Interventions
- DRUG Pentoxifylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-02-04 |
| Est. Completion | 2023-02-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01774487
The ClinicalTrials.gov registry entry for NCT01774487 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pentoxifylline is the first listed.
NCT01774487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01774487 about?
NCT01774487 is a clinical study titled "Pentoxifylline Therapy in Biliary Atresia". The purpose of this study is to determine whether pentoxifylline reduces liver damage in infants with biliary atresia.
What is the current status of trial NCT01774487?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2013-02-04. Estimated completion is 2023-02-20.
What interventions are being tested in trial NCT01774487?
The interventions under investigation include: Pentoxifylline (DRUG).
Who is sponsoring clinical trial NCT01774487?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.